A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis.
about
MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.Pathophysiology of celiac diseaseImpact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine.Molecular Interactions between NAFLD and Xenobiotic Metabolism.Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?Non-Alcoholic Fatty Liver Disease: Current Perspectives and Future Direction in Disease pathogenesis, Treatment and Diagnosis.Variable slope normalization of reverse phase protein arrays.NADPH Oxidases in Chronic Liver DiseasesGenomics and proteomics in liver fibrosis and cirrhosis.Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation.Surface Adjustment of Reverse Phase Protein Arrays using Positive Control Spots.Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice.A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease.
P2860
Q30439971-2C39EF11-2391-43BC-BADC-69ED25938494Q34307239-8D3CAD6A-B62C-4FF1-9511-22EB1D4A153CQ35560129-0932A3BF-00F4-4A98-9482-36B173DF3BCBQ36549795-7CADF2D4-4F6D-4BFB-9F94-6586D55AEA68Q37693238-3D43F0C6-6193-4FF0-8B49-46C81D372D56Q37863141-56CB6FED-6CA6-4D88-8B95-79CC44ECD80AQ38360416-C60F0591-0419-44DA-BEAE-A6A53C8EA22CQ38545364-C3A5C677-C8C9-44A9-AA31-8397A27859CCQ38599090-728867BB-5BCD-46EF-B265-89BF94F982A2Q40462698-E0DBA62A-8464-404C-83FE-43FD4F7502A8Q41469375-3CA3E186-DC4A-4F28-A2CD-0CC1656BA135Q42540737-2B18DE69-271D-4F7E-8B92-0BC5AA6E894BQ43251946-3810E0B1-E481-421E-8D13-647D5EBED099Q46177222-0633F754-BBF5-4116-82A2-47A14A6A99D3Q50786458-52D54E31-BD6B-4171-A1A1-00292B29A078
P2860
A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A systems biology approach to ...... lexed cell signaling analysis.
@ast
A systems biology approach to ...... lexed cell signaling analysis.
@en
type
label
A systems biology approach to ...... lexed cell signaling analysis.
@ast
A systems biology approach to ...... lexed cell signaling analysis.
@en
prefLabel
A systems biology approach to ...... lexed cell signaling analysis.
@ast
A systems biology approach to ...... lexed cell signaling analysis.
@en
P2093
P356
P1433
P1476
A systems biology approach to ...... lexed cell signaling analysis.
@en
P2093
Arian Afendy
Emanuel F Petricoin
Hazem Elariny
Lance A Liotta
Michael Mendoza
Rochelle Collantes
Valerie S Calvert
Zachary Goodman
Zobair M Younossi
P2860
P304
P356
10.1002/HEP.21688
P407
P577
2007-07-01T00:00:00Z